{
    "2020-02-25": [
        [
            {
                "time": "",
                "original_text": "高瓴、兴全下重注 医药“高烧”的AB面:二级热一级慌",
                "features": {
                    "keywords": [
                        "高瓴",
                        "兴全",
                        "医药",
                        "二级市场",
                        "一级市场"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "定增的“诱惑”：FOF罕见现身，社保、养老目标基金也出动",
                "features": {
                    "keywords": [
                        "定增",
                        "FOF",
                        "社保基金",
                        "养老目标基金"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "资本竞逐CXO板块，药石科技定增获兴全基金全额认购",
                "features": {
                    "keywords": [
                        "CXO",
                        "药石科技",
                        "定增",
                        "兴全基金"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "第二单！兴全基金6.5亿全额认购药石科技，资本正加剧涌入这个行业",
                "features": {
                    "keywords": [
                        "兴全基金",
                        "药石科技",
                        "资本涌入",
                        "行业布局"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "瑞伏创投黄瑞瑨：疫情会降低医疗创业公司估值",
                "features": {
                    "keywords": [
                        "瑞伏创投",
                        "疫情",
                        "医疗创业公司",
                        "估值下降"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "高瓴成立创投、入股凯莱英，从早期到一级半的健康布局",
                "features": {
                    "keywords": [
                        "高瓴",
                        "创投",
                        "凯莱英",
                        "健康布局"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}